GC74058
TG8-260
Also known as 4-(1H-imidazol-5-yl)-N-[2-(2-methyl-1H-indol-3-yl)ethyl]benzamide
TG8-260 is a second-generation EP2 antagonist developed to alleviate the pathology of central nervous system and peripheral diseases driven by inflammation
ChemicalCAS2490544-50-6MW344.41FormulaC21H20N4O
- CAS number
- 2490544-50-6
- Molecular weight
- 344.41
- Formula
- C21H20N4O
- Solubility
- DMSO ： 125 mg/mL (362·94 mM; Need ultrasonic)
- InChIKey
- XMWMPTMQNJXLNV-UHFFFAOYSA-N
- Catalogue number
- GC74058
- Brand
- GLPBIO
Computed properties PubChem CID 155128767 · XLogP 3.5 · TPSA 73.6 Ų · H-bond donors 3
- XLogP
- 3.5
- TPSA
- 73.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 2
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES CC1=C(C2=CC=CC=C2N1)CCNC(=O)C3=CC=C(C=C3)C4=CN=CN4
Computed descriptors from PubChem (CID 155128767), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il